On the recordMay 8, 2019
Is it really appropriate to continue to keep charging the taxpayer for those research risks on the back of an old product?
Source
congress.govIs it really appropriate to continue to keep charging the taxpayer for those research risks on the back of an old product?
Kennedy challenges the ongoing taxpayer funding for older products.
Share
More from Joseph P. Kennedy III
This is, in all likelihood, my last committee hearing as well. It has been an extraordinary honor and pleasure and privilege for me to join all of you on the best committee in Congress.
Mistrust amongst people of color isn't surprising considering the long history of structural racism and unethical medical experimentation on this population.
In other parlance, it is countercyclical, right? When you have an economic downturn, Medicaid enrollment increases, right?